PetMed Express Analyst Price Targets

Wall Street analyst price targets and consensus rating for PetMed Express (PETS).

Price Target Range — 6 Quarters

Analyst Consensus — 2 Analysts

1Hold

1Sell

Consensus RatingHold# Analysts2Avg. Consensus PT$2Upside to Avg. PT+104.6%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Sep 25, 2026	Morgan Stanley	Erin Wright	PT Cut	Underweight	$2→$1
Apr 17, 2025	Morgan Stanley	Erin Wright	PT Cut	Underweight	$4→$3
Aug 7, 2024	Lake Street	Ryan Meyers	Downgrade	Buy→Hold	$7→$4
Jun 12, 2024	Lake Street	Ryan Meyers	PT Cut	Buy	$9→$7
Jun 12, 2024	Morgan Stanley	Erin Wright	PT Cut	Underweight	$7→$4
Feb 9, 2024	Lake Street	Ryan Meyers	PT Cut	Buy	$13→$9
Nov 16, 2023	Morgan Stanley	Erin Wright	PT Cut	Underweight	$7→$7

Analyst Ratings News

PRO
Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $1.4

Morgan Stanley analyst Erin Wright maintains PetMed Express (NASDAQ:PETS) with a Underweight and lowers the price target from $2.15 to $1.4.

Benzinga Newsdesk

From Christmas Treats To GPS Collars: How Americans Are Still Spending On Pets And What It Means For Pet Care Stocks In 2026

Pet spending stayed resilient in 2025 despite inflation. See which pet care stocks Wall Street is watching heading into 2026.

Namrata Sen

PRO
Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $3.2

Morgan Stanley analyst Erin Wright maintains PetMed Express (NASDAQ:PETS) with a Underweight and lowers the price target from $3.5 to $3.2.

Benzinga Newsdesk

PRO
Lake Street Downgrades PetMed Express to Hold, Lowers Price Target to $3.5

Lake Street analyst Ryan Meyers downgrades PetMed Express (NASDAQ:PETS) from Buy to Hold and lowers the price target from $7 to $3.5.

Benzinga Newsdesk

PRO
Lake Street Maintains Buy on PetMed Express, Lowers Price Target to $7

Lake Street analyst Ryan Meyers maintains PetMed Express (NASDAQ:PETS) with a Buy and lowers the price target from $9 to $7.

Benzinga Newsdesk

PRO
Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $3.5

Morgan Stanley analyst Erin Wright maintains PetMed Express (NASDAQ:PETS) with a Underweight and lowers the price target from $6.5 to $3.5.

Benzinga Newsdesk

PetMed Express Inc

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

PetMed Express Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $1.4

From Christmas Treats To GPS Collars: How Americans Are Still Spending On Pets And What It Means For Pet Care Stocks In 2026

PRO
Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $3.2

PRO
Lake Street Downgrades PetMed Express to Hold, Lowers Price Target to $3.5

PRO
Lake Street Maintains Buy on PetMed Express, Lowers Price Target to $7

PRO
Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $3.5

People Also Watch

People Also Watch

PetMed Express Inc

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

PetMed Express Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROMorgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $1.4

From Christmas Treats To GPS Collars: How Americans Are Still Spending On Pets And What It Means For Pet Care Stocks In 2026

PROMorgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $3.2

PROLake Street Downgrades PetMed Express to Hold, Lowers Price Target to $3.5

PROLake Street Maintains Buy on PetMed Express, Lowers Price Target to $7

PROMorgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $3.5

People Also Watch

People Also Watch

PRO
Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $1.4

PRO
Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $3.2

PRO
Lake Street Downgrades PetMed Express to Hold, Lowers Price Target to $3.5

PRO
Lake Street Maintains Buy on PetMed Express, Lowers Price Target to $7

PRO
Morgan Stanley Maintains Underweight on PetMed Express, Lowers Price Target to $3.5